Clinical Research Directory

Inclusion Criteria: * Adults aged 18 to 60 years, inclusive; * Clinical diagnosis of central serous chorioretinopathy (CSC); * Completion of fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) examinations; * Completion of ultra-widefield optical coherence tomography angiography (UWF-OCTA) imaging; * No prior history of pharmacological or surgical treatment for CSC; * Ability and willingness to provide written informed consent. Exclusion Criteria: -Presence of other ophthalmic diseases that may affect retinal or choroidal imaging or analysis, including but not limited to: Significant refractive media opacities interfering with OCTA imaging (e.g., severe cataract, vitreous hemorrhage); * Presence of systemic diseases that may affect study outcomes or participant safety; * Pregnant or lactating women; * History of psychiatric or mental disorders that may impair compliance; * Hemorrhagic diathesis or requirement for long-term anticoagulant therapy; * History of long-term systemic medication use that may affect choroidal or retinal circulation; * Presence of severe and/or uncontrolled comorbid medical conditions, including but not limited to: Uncontrolled diabetes mellitus; Uncontrolled hypertension; Active uncontrolled infection; Chronic obstructive pulmonary disease (COPD) with dyspnea at rest; * History of intraocular surgery or intravitreal injection within the past 6 months; * High refractive error defined as: Spherical equivalent (SE) \< -6.0 diopters or \> +3.0 diopters, or Axial length (AL) \> 26.0 mm; -Any other condition that, in the opinion of the investigator, would make participation unsafe or interfere with protocol adherence.